Task: Answer the multiple choice question.
Query: Which drug exhibits a 14.625\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a.) CN(C)S(=O)(=O)c1cc(NC(=O)CN2CCN(c3ccccc3)CC2)ccc1Cl
b.) Cc1cc(C)cc(NC(=O)C(=S)NCc2ccccc2)c1
c.) c1csc(-c2nc(-c3ccc(-c4ccon4)s3)no2)c1
Answer: b. Cc1cc(C)cc(NC(=O)C(=S)NCc2ccccc2)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cc(C)cc(NC(=O)C(=S)NCc2ccccc2)c1
Cc1cc(C)cc(NC(=O)C(=S)NCc2ccccc2)c1
2-(benzylamino)-N-(3,5-dimethylphenyl)-2-sulfanylideneacetamide